APA aipamena

Dalgleish, A. G., Stebbing, J., Adamson, D. J. A., Arif, S. S., Bidoli, P., Chang, D., . . . Mudan, S. S. (2016). Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer. Br J Cancer.

Chicago Style aipamena

Dalgleish, Angus G., et al. "Randomised, Open-label, Phase II Study of Gemcitabine With and Without IMM-101 for Advanced Pancreatic Cancer." Br J Cancer 2016.

MLA aipamena

Dalgleish, Angus G., et al. "Randomised, Open-label, Phase II Study of Gemcitabine With and Without IMM-101 for Advanced Pancreatic Cancer." Br J Cancer 2016.